Archives

by in
Entry Author Date Location
What Are the Hottest Targets in Biotech Today? 04/23/12 National
Abbott’s Humira, the 3rd-in-Class Drug That Toppled Lipitor as No. 1 04/16/12 National
Investing in Biotech Isn’t Just for Investors Anymore 04/09/12 National
Biotech Can’t Sidestep Cost-Effectiveness Anymore 04/02/12 National
Some Tongue-in-Cheek Fantasy Baseball (and Biotech) Picks 03/26/12 National
Biotech’s New Frontier: Europe? 03/19/12 National
Life Sciences News Roundup: InflammaGen, HemaQuest, ImThera & More 03/16/12 San Diego
AIDS Drugs Were the Start. Let’s See More FDA Accelerated Approvals 03/12/12 National
San Diego Life Sciences Roundup: Aragon, Illumina, CareFusion, & More 03/08/12 San Diego
Five Reasons Illumina Should Fight Roche’s Insulting Low-Ball Bid 03/05/12 National
Bruce Booth, a LifeSciVC Shining Some Much-Needed Light on Biotech 02/27/12 National
Oh, And One More Thing: A Wowser Moment in DNA Sequencing 02/21/12 National
Xconomy’s Timmerman Wins National Journalism Award 02/17/12 National
Never Back Smug: A Lesson for Life Sciences From Newt Gingrich 01/30/12 National
San Diego Life Sciences Roundup: Illumina, Sequenom, Acutus, & More 01/26/12 San Diego
Biotech Is Raising More Cash, But Don’t Be Fooled: Startups are Hurting 01/23/12 National
San Diego Life Sciences News: AnaptysBio, Life, NeuroGenetic & More 01/12/12 San Diego
Five Myths You’ll Hear This Week at the JP Morgan Healthcare Conference 01/09/12 National
Amgen CEO Kevin Sharer’s Report Card: C 12/19/11 National
The Hepatitis C Market: Biotech’s Version of the Daytona 500 12/12/11 National
Steve Jobs’s Dying Realization About Biology and Technology 12/05/11 National
Buyouts, Quantified Health, & More San Diego Life Sciences News 12/01/11 San Diego
Versant Ventures’ Partner Cuts Back on Biotech Work to Spend Time With Family. For Real 11/28/11 National
Eli Lilly CEO John Lechleiter on Tackling the Pharmaceutical R&D Crisis (Part 2) 11/22/11 National
Eli Lilly CEO John Lechleiter on Tackling the Pharmaceutical R&D Crisis (Part 1) 11/21/11 National
Martino Joins Ambit, Nordhoff Leaves Gen-Probe, Swarmology Raises $1.2M, and More San Diego Life Sciences News 11/17/11 San Diego
The Herman Cain-Inspired “1-100-0″ Plan for Personalized Medicine? 11/14/11 National
Groupon: The IPO With More Sizzle, and Money, Than the Entire Biotech IPO Class of 2011 11/07/11 National
TEDMED Walking, FDA Clears Pacira Drug, Zogenix Close to NDA, & More San Diego Life Sciences News 11/03/11 San Diego
The Cancer Drug Dark Ages Are Coming to an End 10/31/11 National
Page 3 of 5 « previous page · next page »

Xconomy Events Across the Network

XSITE 2013: Boston’s Tech Revival

Boston · 6/19/13
9:00 am

More Xconomy Events

Xconomy’s Most Popular

  1. Don’t Panic, But We’ve Passed Peak Apple. And Google. And Facebook.
  2. With Big Bucks Chasing Big Data, Will Consumers Get a Cut?
  3. Zillions of Biotech Conferences Want You. Which Should You Attend?
  4. Profiles in Long-Termism: Sarepta Therapeutics CEO Chris Garabedian
  5. 11 Reasons Why Flickr, Not Facebook, Is the Place to Put Your Photos

Xconomy on Demand

Did you miss something? Don't despair…

Xconomy offers a number of ways to subscribe for free!

Subscribe Now
IDG Tech Network
Protected by Mozy
Eventbrite - events made easy

Business, life sciences, and technology news — covering Boston, Seattle, San Diego, Detroit, San Francisco, New York, Boulder/Denver, Texas and beyond.

© 2007-2013, Xconomy, Inc. Xconomy is a registered service mark of Xconomy, Inc. All rights reserved.

Website development support from Andrew Koyfman with design support from Rob Hunter.